Antimicrobial foam dressing substitution

AC-2025-047ClosedFast Track· Wound Care· Owner: Sarah Okafor· Target decision: Dec 16, 2025
View the Aval
overviewevidenceevaluationfinancialimplementationdecisionvalueaudit
Problem

Incumbent silver foam line repriced +18% at renewal; equivalent products available at lower cost with better conformability feedback.

Current standard

Incumbent silver foam dressing line.

Technology
Silver foam dressing line substitution
Vendor
DermaCare
Requested by
Jenna Kowalski, NP — Nurse Practitioner, Wound Care
Submitted
Nov 25, 2025
Reasons
Cost reduction · Supply disruption
Urgency
routine
Est. patients affected / yr
2,100
Network-connected
No
Replaces existing product
Yes
Triage assessment
DimensionWeightScore /5
Clinical impact
Like-for-like substitution
30%2
Safety
Same antimicrobial class
25%2
Financial materiality
$74K category
20%3
Workflow disruption
None
15%1
Organizational risk
Commodity
10%1
Weighted triage score40 / 100

Low-risk substitution with established evidence — Fast Track with 2-week sample evaluation.

Stakeholders
Stakeholders are assigned at triage.